{
    "nct_id": "NCT06062017",
    "official_title": "The Effects of Water and Potassium Supplementation on Cardiovascular and Kidney Function in Young Adults",
    "inclusion_criteria": "* Between the ages of 18-30 years\n* Resting blood pressure no higher than 150/90 mmHg\n* BMI below 35 kg/m2\n* Free of any metabolic disease (e.g., diabetes) kidney disease, pulmonary disorders (e.g., COPD), cardiovascular disease (peripheral vascular, cardiac, or cerebrovascular), no autoimmune diseases, and no history of cancer.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 30 Years",
    "exclusion_criteria": "* Have any precluding medical conditions (i.e. hemophilia) or medication (Pradaxa, Eliquis, etc.) that prevent participants from giving blood.\n* Are currently pregnant or trying to become pregnant.\n* take any of the following medications that are contraindicated with potassium supplementation:\n* Renin-angiotensin-aldosterone system (RAAS) blockers: Candesartan , Eprosartan, Irbesartan, Losartan, Olmesartan, Telmisartan\n* Non -steroidal anti-inflammatory medications: Aspirin, Ibuprofen, Naproxen\n* Non-selective beta-blockers: Pindolol, Penbutolol, Oxprenolol, Propranolol, Nadolol, Sotalol, Timolol, Tertatolol\n* Calcineurin inhibitors: Cyclosporine\n* Heparin (or other blood thinning medications)",
    "miscellaneous_criteria": ""
}